| Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial G Theron, L Zijenah, D Chanda, P Clowes, A Rachow, M Lesosky, W Bara, ... The Lancet 383 (9915), 424-435, 2014 | 554 | 2014 |
| Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages D Stucki, D Brites, L Jeljeli, M Coscolla, Q Liu, A Trauner, L Fenner, ... Nature genetics 48 (12), 1535-1543, 2016 | 377 | 2016 |
| Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic … JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky, P Gina, N Mehta, ... The Lancet 387 (10024), 1187-1197, 2016 | 285 | 2016 |
| Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay—a clinical validation study A Rachow, A Zumla, N Heinrich, G Rojas-Ponce, B Mtafya, K Reither, ... PloS one 6 (6), e20458, 2011 | 244 | 2011 |
| Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment SO Friedrich, A Rachow, E Saathoff, K Singh, CD Mangu, R Dawson, ... The lancet Respiratory medicine 1 (6), 462-470, 2013 | 213 | 2013 |
| Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study M Bates, J O'Grady, M Maeurer, J Tembo, L Chilukutu, C Chabala, ... The Lancet infectious diseases 13 (1), 36-42, 2013 | 208 | 2013 |
| Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study A Rachow, P Clowes, E Saathoff, B Mtafya, E Michael, EN Ntinginya, ... Clinical infectious diseases 54 (10), 1388-1396, 2012 | 192 | 2012 |
| Post-tuberculosis lung health: perspectives from the First International Symposium BW Allwood, MM Van Der Zalm, AFS Amaral, A Byrne, S Datta, U Egere, ... The International Journal of Tuberculosis and Lung Disease 24 (8), 820-828, 2020 | 171 | 2020 |
| Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study D Portevin, F Moukambi, P Clowes, A Bauer, M Chachage, NE Ntinginya, ... The Lancet infectious diseases 14 (10), 931-938, 2014 | 162 | 2014 |
| Post-tuberculosis lung disease: clinical review of an under-recognised global challenge BW Allwood, A Byrne, J Meghji, A Rachow, MM van der Zalm, OD Schoch Respiration 100 (8), 751-763, 2021 | 153 | 2021 |
| Clinical standards for the assessment, management and rehabilitation of post-TB lung disease GB Migliori, FM Marx, N Ambrosino, E Zampogna, HS Schaaf, ... The International Journal of Tuberculosis and Lung Disease 25 (10), 797-813, 2021 | 146 | 2021 |
| Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study G Theron, J Peter, L Zijenah, D Chanda, C Mangu, P Clowes, A Rachow, ... BMC infectious diseases 15, 1-12, 2015 | 108 | 2015 |
| Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients N Heinrich, R Dawson, J du Bois, K Narunsky, G Horwith, AJ Phipps, ... Journal of Antimicrobial Chemotherapy 70 (5), 1558-1566, 2015 | 96 | 2015 |
| Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic J O'Grady, M Bates, L Chilukutu, J Mzyece, B Cheelo, M Chilufya, ... Clinical infectious diseases 55 (9), 1171-1178, 2012 | 92 | 2012 |
| Xpert MTB/RIF Ultra assay for the diagnosis of pulmonary tuberculosis in children: a multicentre comparative accuracy study I Sabi, A Rachow, D Mapamba, P Clowes, NE Ntinginya, M Sasamalo, ... Journal of Infection 77 (4), 321-327, 2018 | 85 | 2018 |
| The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatment I Honeyborne, B Mtafya, PPJ Phillips, M Hoelscher, EN Ntinginya, ... Journal of clinical microbiology 52 (8), 3064-3067, 2014 | 83 | 2014 |
| The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially … R Bowness, MJ Boeree, R Aarnoutse, R Dawson, A Diacon, C Mangu, ... Journal of Antimicrobial Chemotherapy 70 (2), 448-455, 2015 | 74 | 2015 |
| Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients M Bates, J O’Grady, P Mwaba, L Chilukutu, J Mzyece, B Cheelo, ... Public Library of Science 7 (7), e40774, 2012 | 74 | 2012 |
| Tuberculosis bacillary load, an early marker of disease severity: the utility of tuberculosis molecular bacterial load assay W Sabiiti, K Azam, ECW Farmer, D Kuchaka, B Mtafya, R Bowness, ... Thorax 75 (7), 606-608, 2020 | 71 | 2020 |
| TB sequel: incidence, pathogenesis and risk factors of long-term medical and social sequelae of pulmonary TB–a study protocol A Rachow, O Ivanova, R Wallis, S Charalambous, I Jani, N Bhatt, ... BMC pulmonary medicine 19, 1-9, 2019 | 67 | 2019 |
